The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer.
 
Martin W. Schoen
No Relationships to Disclose
 
Kenneth Robert Carson
Employment - Flatiron Health; Tempus
Leadership - Tempus
Stock and Other Ownership Interests - Flatiron Health; Tempus
Research Funding - Celgene (Inst); Kyowa Hakko Kirin
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Flatiron Health
 
Suhong Luo
No Relationships to Disclose
 
Seth Eisen
Research Funding - Bristol-Myers Squibb
 
Melissa Andrea Reimers
No Relationships to Disclose
 
Bettina F. Drake
No Relationships to Disclose
 
Charles L. Bennett
Consulting or Advisory Role - Oncology Analytics
Research Funding - Pharmacyclics/Janssen (Inst)
 
Eric Marshall Knoche
Stock and Other Ownership Interests - Bristol-Myers Squibb/Pfizer (I); Cardiff Oncology; Exelixis; Gilead Sciences (I); Johnson & Johnson/Janssen (I); Karyopharm Therapeutics; Merck (I); Roche/Genentech (I)
 
Yan Yan
No Relationships to Disclose
 
Kristen Marie Sanfilippo
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Amgen
Other Relationship - Health Services Advisory Group